To verify whether CCL5 is one of the key factors released from CD4+ T cells to increase neighboring PCa chemoresistance, we directly added CCL5 recombinant proteins into C4‐2 and CWR22RV1 cells. The gene discussed is CD4; the disease is posterior cortical atrophy.